The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreAs seen on ISRAEL21c.
Supermarkets could soon be selling yogurts, milkshake powders and other products offering relief to the millions of people who have Crohn’s disease or colitis.
An Israeli startup is preparing for clinical trials of a natural supplement derived from cow milk that will reduce inflammation – and reduce patients’ reliance on prescription medication.
Scientists now know that mothers’ milk contains exosomes, tiny capsules of microRNA — the molecules that regulate protein production in their bodies – that combat inflammation and other symptoms associated with i (opens in a new tab)nflammatory bowel disease (IBD) such as Crohn’s and colitis.
Exosomm is a biotech startup developing a way to use exosomes to treat inflammatory bowel disease (IBD) through food. Exosomm Co-founder and CEO Netta Granot is a Technion alumna.